Appeal No. 97-0056 Page 8
Application No. 07/791,156
that the patentable distinction resides in the non-application
of the treatment composition to those areas of the fabric
intended for receipt of an adhesive, as discussed above.
Since we have sustained the examiner's position that the
application of anti-fray compositions to a fabric of the type
disclosed by Duval is well known in the art and since the
claims do not preclude application of the treatment
composition over the entire fabric, including those areas
intended for receipt of an adhesive, we affirm the examiner's
decision rejecting claim 57 as obvious without further
consideration. See In re Baxter Travenol Labs., 952 F.2d 388,
391, 21 USPQ2d 1281, 1285 (Fed. Cir. 1991).
CONCLUSION
To summarize, the decision of the examiner to reject
claims 57 through 60 under 35 U.S.C. § 103 is AFFIRMED.
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 Next
Last modified: November 3, 2007